Screening compound: InChI=1S/C16H10F3N3O2/c17-16(18,19)10-4-3-5-11(8-10)20-14-12(9-23)15(24)22-7-2-1-6-13(22)21-14/h1-9,20H

Screening compound: InChI=1S/C16H10F3N3O2/c17-16(18,19)10-4-3-5-11(8-10)20-14-12(9-23)15(24)22-7-2-1-6-13(22)21-14/h1-9,20H
Screening compound: InChI=1S/C16H10F3N3O2/c17-16(18,19)10-4-3-5-11(8-10)20-14-12(9-23)15(24)22-7-2-1-6-13(22)21-14/h1-9,20H alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C16H10F3N3O2/c17-16(18,19)10-4-3-5-11(8-10)20-14-12(9-23)15(24)22-7-2-1-6-13(22)21-14/h1-9,20H

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y070-0376

Molecular Formula

C16H10F3N3O2 (C16 H10 F3 N3 O2)

Compound Name

4-oxo-2-{[3-(trifluoromethyl)phenyl]amino}-4H-pyrido[1,2-a]pyrimidine-3-carbaldehyde

IUPAC name

4-oxo-2-{[3-(trifluoromethyl)phenyl]amino}-4H-pyrido[12-a]pyrimidine-3-carbaldehyde

SMILES

O=CC1=C(Nc2cccc(C(F)(F)F)c2)N=C(C=CC=C2)N2C1=O

InChI

InChI=1S/C16H10F3N3O2/c17-16(18,19)10-4-3-5-11(8-10)20-14-12(9-23)15(24)22-7-2-1-6-13(22)21-14/h1-9,20H

InChI Key

KKTRDLDCCQNKIF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01072121

InChI=1S/C16H10F3N3O2/c17-16(18,19)10-4-3-5-11(8-10)20-14-12(9-23)15(24)22-7-2-1-6-13(22)21-14/h1-9,20H in Drug Discovery

Included in Screening Libraries

Antiparasite Library (23996 compounds)

Antiviral Annotated Library (21441 compounds)

Human Receptors Annotated Library (5376 compounds)

KRAS-Targeted Library (16000 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Covalent Inhibitors Library (7986 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Agro:
  • Agro
Targets:
  • Kinases
Structure:
  • Cyclic compounds
  • 3D
  • Fragments

References: we are preparing a list of scientific research reports with InChI=1S/C16H10F3N3O2/c17-16(18,19)10-4-3-5-11(8-10)20-14-12(9-23)15(24)22-7-2-1-6-13(22)21-14/h1-9,20H chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C16H10F3N3O2/c17-16(18,19)10-4-3-5-11(8-10)20-14-12(9-23)15(24)22-7-2-1-6-13(22)21-14/h1-9,20H?
Check Price and Availability of InChI=1S/C16H10F3N3O2/c17-16(18,19)10-4-3-5-11(8-10)20-14-12(9-23)15(24)22-7-2-1-6-13(22)21-14/h1-9,20H, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C16H10F3N3O2/c17-16(18,19)10-4-3-5-11(8-10)20-14-12(9-23)15(24)22-7-2-1-6-13(22)21-14/h1-9,20H you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C16H10F3N3O2/c17-16(18,19)10-4-3-5-11(8-10)20-14-12(9-23)15(24)22-7-2-1-6-13(22)21-14/h1-9,20H
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C16H10F3N3O2/c17-16(18,19)10-4-3-5-11(8-10)20-14-12(9-23)15(24)22-7-2-1-6-13(22)21-14/h1-9,20H
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C16H10F3N3O2/c17-16(18,19)10-4-3-5-11(8-10)20-14-12(9-23)15(24)22-7-2-1-6-13(22)21-14/h1-9,20H available by request